Overview Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic Gastritis Status: Recruiting Trial end date: 2024-12-01 Target enrollment: Participant gender: Summary This study is to evaluate the efficacy and safety of DA-5219 in patients with acute or chronic gastritis Phase: Phase 3 Details Lead Sponsor: Dong-A ST Co., Ltd.